期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

卵巢癌化疗研究进展 被引量：3

Progress of chemotherapy in ovarian cancer
下载PDF
导出
摘要 化疗是治疗卵巢癌的重要手段。对于早期卵巢癌 ,腹腔和全身化疗可以防止复发 ,提高治愈率 ;对于晚期卵巢癌 ,化疗可以缓解症状 ,延长患者生存期。现综述近年有关卵巢癌化疗方面的研究进展。
作者 王巍
机构地区 佛山市人民医院肿瘤医院内科
出处 《国外医学（肿瘤学分册）》 2004年第5期387-390,共4页 Foreign Medical Sciences (Cancer Section)
关键词 卵巢癌 辅助化疗 研究进展 化学疗法 腹腔化疗
分类号 R737.31 [医药卫生—肿瘤] R730.56 [医药卫生—肿瘤]
  • 相关文献

参考文献22

  • 1Trimbos JB, Parmar M, Vergote I, et al. International Collaborative Ovarian Neoplasm trial 1 and Adjuvant ChemoTherapy In Ovari an Neoplasm trial: two parallel randomized phase Ⅲ trials of adjuvant chemotherapy in patients with early-stage ovarian carcinoma. J Natl Cancer Inst, 2003, 95(2): 105-112.
  • 2Trimbos JB, Vergote I, Bolis G, et al. Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in ovarian Neoplasm trial. J Natl Cancer Inst,2003, 95(2): 113-125.
  • 3Ho CM, Chien TY, Shih BY, et al. Evaluation of complete surgical staging with pelvic and para-aortic lympbadenectomy and paclitaxel plus carboplatin chemotherapy for improvement of survival in stage I ovarian clear cell carcinoma. Gynecol Oncol, 2003, 88 (3): 394-399.
  • 4Sorbe B, Swedish-Norgewian ovarian Cancer Study Group. Consolidation treatment of advanced (FIGO stage Ⅲ) ovarian carcinoma in complete surgical remission after induction chemotherapy: a randomized, controlled, clinical trial comparing whole abdominal radiotherapy, chemotherapy, and no further treatment. Int J Gynecol Cancer,2003, 13(3):278-286.
  • 5Varia MA, Stehman FB, Bundy BN, et al. Intraperitoneal radioactive phosphorus (32 p) versus observation after negative second-look laparotomy for stage Ⅲ ovarian carcinoma: a randomized trial of the Gynecologic Oncology Group. J Clin Oncol, 2003, 21 (15): 2849-2855.
  • 6McGuire WP, Hoskins WJ, Brady MF, et al. Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage Ⅲ and stage V ovarian cancer. N Engl J Med, 1996, 334(1): 1-6.
  • 7Ozols RF. Update of the NCCN ovarian cancer practice guidelines.Oncology (Huntingt), 1997, 11(11A): 95-105.
  • 8Mnggia FM, Braly PS, Brady MF, et al. Phase Ⅲ randomized study of cisplatin versus paclitaxel versus cisplatin and paclitaxel in patients with suboptimal stage Ⅲ or V ovarian cancer: a gynecologic oncology group study. J Clin Oncol, 2000, 18(1):106-115.
  • 9Markman M, Liu PY, Wilczynski S, et al. Phase Ⅲ randomized trial of 12 versus 3 months of maintenance paclitaxel in patients with advanced ovarian cancer after complete response to platinum and paclitaxel-based chemotherapy: a Southwest Oncology Group and Gynecologic Oncology Group trial. J Clin Oncol, 2003, 21(13): 2460-2465.
  • 10Omura GA, Brady MF, Look KY, et al. Phase Ⅲ trial of paclitaxel at two dose levels, the higher dose accompanied by filgrastim at two dose levels in platinum-pretreated epithelial ovarian cancer: an intergroup study. J Clin Oncol, 2003, 21(15): 2843-2848.

同被引文献24

引证文献3

二级引证文献27

国外医学（肿瘤学分册）
2004年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部